Wang Y P, Bennett C, Pan T
West China Hospital of Sichuan University, Gasstroenterology, South Renmin Road, Chengdu, Sichuan, China, 610041.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004276. doi: 10.1002/14651858.CD004276.pub2.
The treatment of early gastric cancer (EGC) using an endoscopy, namely, endoscopic mucosal resection (EMR), has been adopted for about 20 years, but the effectiveness and the safety of the modality are still controversial. The quality of these trials has not been assessed systematically.
The purpose of this review was to compare the effectiveness and the safety of EMR with gastrectomy for the treatment of EGC.
Searches were conducted on the Cochrane Central Register of Controlled Trials - CENTRAL (which includes the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group Trials Register) on The Cochrane Library (Issue 1 2005) MEDLINE (1966 to March 2005) and EMBASE (1980 to March 2005), CINAHL (1985-March 2005) and CBM (Chinese BioMedical Database 1982 -2002). Reference lists from trials selected by electronic searching were handsearched to identify further relevant trials. Published abstracts from conference proceedings from the United European Gastroenterology Week (published in Gut) and Digestive Disease Week (published in Gastroenterology) were handsearched. Members of the Cochrane UGPD Group, and experts in the field were contacted and asked to provide details of outstanding clinical trials and any relevant unpublished materials
All randomised controlled trials of EGC patients involving a treatment arm of EMR and a comparison arm of gastrectomy were to be included, but no RCTs were found.
Three reviewers (YP Wang, C Bennett and T Pan) independently assessed the eligibility of potential trials and extracted the data.
There are no included randomised control trials for the systematic review. Available evidence derived from non-randomised controlled trials is discussed in the main text of this review.
AUTHORS' CONCLUSIONS: There is a lack of randomised controlled trials in which EMR is compared with gastrectomy for EGC. There is a need for well designed randomised controlled trials to determine the effects of EMR compared to gastrectomy.
使用内窥镜治疗早期胃癌(EGC),即内镜下黏膜切除术(EMR),已应用约20年,但该治疗方式的有效性和安全性仍存在争议。这些试验的质量尚未得到系统评估。
本综述的目的是比较EMR与胃切除术治疗EGC的有效性和安全性。
检索了Cochrane对照试验中心注册库(CENTRAL)(包括Cochrane上消化道和胰腺疾病组试验注册库)、Cochrane图书馆(2005年第1期)、MEDLINE(1966年至2005年3月)、EMBASE(1980年至2005年3月)、CINAHL(1985年至2005年3月)和CBM(中国生物医学数据库1982 - 2002年)。对通过电子检索选择的试验的参考文献列表进行手工检索,以识别更多相关试验。对欧洲胃肠病学联合周会议论文集(发表于《肠道》)和消化系统疾病周会议论文集(发表于《胃肠病学》)的已发表摘要进行手工检索。联系了Cochrane UGPD组的成员和该领域的专家,要求他们提供未发表的优秀临床试验和任何相关未发表材料的详细信息。
纳入所有涉及EMR治疗组和胃切除术对照组的EGC患者随机对照试验,但未找到随机对照试验。
三位评审员(王YP、C·贝内特和潘T)独立评估潜在试验的入选资格并提取数据。
本系统综述未纳入随机对照试验。本综述正文讨论了来自非随机对照试验的现有证据。
缺乏将EMR与胃切除术用于EGC进行比较的随机对照试验。需要设计良好的随机对照试验来确定EMR与胃切除术相比的效果。